Alosetron for irritable bowel syndrome - Reply

AW Mangel

RTI uses cookies to offer you the best experience online. By and clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.

Alosetron for irritable bowel syndrome - Reply

Mangel, AW. (2000). Alosetron for irritable bowel syndrome - Reply. Lancet, 356(9246), 2009-2010.

Copy citation

Recent Publications

Article

What are the labor market returns to MBAs from broad-access institutions?

Article

Biomarker testing in patients diagnosed with advanced/metastatic medullary thyroid cancer in the United States

Article

The daily association between affect and alcohol use: A meta-analysis of individual participant data

Article

Alosetron for irritable bowel syndrome - Reply

Publications Info

Allen W. Mangel

Recent Publications

What are the labor market returns to MBAs from broad-access institutions?

Biomarker testing in patients diagnosed with advanced/metastatic medullary thyroid cancer in the United States

The daily association between affect and alcohol use: A meta-analysis of individual participant data

The use of patient experience feedback in rehabilitation quality improvement and codesign activities

Partner With Us

Site

Alosetron for irritable bowel syndrome - Reply

Publications Info

Meet the Experts

Allen W. Mangel

Recent Publications

What are the labor market returns to MBAs from broad-access institutions?

Biomarker testing in patients diagnosed with advanced/metastatic medullary thyroid cancer in the United States

The daily association between affect and alcohol use: A meta-analysis of individual participant data

The use of patient experience feedback in rehabilitation quality improvement and codesign activities